Full Text View
Tabular View
No Study Results Posted
Related Studies
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
This study is ongoing, but not recruiting participants.
Study NCT00069784   Information provided by Sanofi-Aventis
First Received: October 1, 2003   Last Updated: March 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Intolerance
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Hyperglycemia
Metabolic Diseases
Interventions listed in this trial
insulin glargine (HOE901)
omega-3 fatty acids
placebo
Additional drug interventions recognized in this trial
Glargine
Insulin
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services